Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
NPJ Precision Oncology|September 17, 2024
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinomaKazuki Nishimura, Kiyoshi Takahara, Kazumasa Komura, et al.
Urologic Oncology|July 11, 2026
Efficacy and safety of first-line immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients on hemodialysisHidetsugu Takahashi, Wataru Fukuokaya, Takafumi Yanagisawa, et al.
International Journal of Clinical Oncology|July 27, 2026
Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinomaMamoru Hashimoto, Lan Inoki, Yutaka Yamamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 2, 2026
Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in JapanKeita Kobayashi, Kei Daizumoto, Takuya Tsujino, et al.
Oncogene|September 21, 2021
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agentsKazumasa Komura, Teruo Inamoto, Takuya Tsujino, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in JapanShuichi Tatarano, Makito Miyake, Yu Osaki, et al.
Anticancer Research|May 27, 2026
Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell CarcinomaYuya Oishi, Yuto Matsushita, Shinya Watanabe, et al.
Anticancer Research|August 1, 2025
Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With ImmunotherapyKoichi Sugimoto, Takafumi Minami, Shingo Toyoda, et al.
BJU International|July 24, 2020
Risk stratification for the prediction of overall survival could assist treatment decision-making at diagnosis of castration-resistant prostate cancer: a multicentre collaborative study in JapanTaizo Uchimoto, Kazumasa Komura, Wataru Fukuokaya, et al.
Biotechniques|June 28, 2025
Dual compartment utility of BRET-based biosensors for PPP2R5A/B56α, a cancer-associated B regulatory subunit of PP2AHirofumi Yamauchi, Atsuro Oishi, Masahiko Ajiro, et al.
Pageof 7